TP53I13 Antilichaam - C-terminalgebied: FITC (ARP51702_P050-FITC)

Tumor protein p53 inducible protein 13

DSCP1

90313

Q8NBR0

NP_612358

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit

The immunogen is a synthetic peptide directed towards the C terminal region of human TP53I13

TP53I13 may act as a tumor suppressor. It inhibits tumor cell growth, when overexpressed. TP53I13 was up-regulated by genotoxic stresses of adriamycin and/or ultraviolet beam irradiation in a p53-dependent manner

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Cow: 93%; Dog: 86%; Guinea Pig: 93%; Horse: 93%; Human: 100%; Mouse: 93%; Rabbit: 93%; Rat: 93%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

42kDa

Hata, T., (2004) Int. J. Oncol. 24 (3), 513-520

Wet Ice

393

TP53I13

TP53I13

Rabbit

Tumor protein p53-inducible protein 13

NM_138349

YWGPTADSQDTVAAVLKRRLLQPSRRVKRSRRRPLLPPTPDSGPEGESSE